Literature DB >> 8607880

Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3.

S Mikami1, S Kawashima, K Kanazawa, K Hirata, Y Katayama, H Hotta, Y Hayashi, H Ito, M Yokoyama.   

Abstract

Nitric oxide is known to participate in the immune and inflammatory processes. In this study, we investigated the production of nitric oxide (NO) in murine viral myocarditis induced by coxsackievirus B3. The expression of inducible NO synthase (iNOS) mRNA in the heart first appeared on day 4 after virus inoculation and it was detectable for one month by reverse transcriptase-polymerase chain reaction (RT-PCR) methods. iNOS activity which was determined by the conversion of L-[3H]arginine to L-[3H]citrulline was increased on day 4 and revealed its peak on day 8. Immunohistochemistry on day 7 showed increased iNOS staining mainly in infiltrating macrophages and polymorphonuclear leukocytes. Thus, NO is thought to be produced in the heart and play an important role in a murine model of coxsackievirus B3-induced viral myocarditis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607880     DOI: 10.1006/bbrc.1996.0519

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.

Authors:  C Zaragoza; C Ocampo; M Saura; M Leppo; X Q Wei; R Quick; S Moncada; F Y Liew; C J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Nitric oxide and macrophage antiviral extrinsic activity.

Authors:  F Benencia; M C Courreges
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 4.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

5.  Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model.

Authors:  J K Sandhu; H F Privora; G Wenckebach; H C Birnboim
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Effect of nitric oxide on poliovirus infection of two human cell lines.

Authors:  J A López-Guerrero; L Carrasco
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 7.  Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management.

Authors:  M T Kearney; J M Cotton; P J Richardson; A M Shah
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

Review 8.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

9.  Molecular Aspects of Myocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.663

Review 10.  Nitric oxide and virus infection.

Authors:  T Akaike; H Maeda
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.